Home > Boards > US OTC > Cannabis >

Cannabix Technologies Inc. (BLOZF)

Add BLOZF Price Alert      Hide Sticky   Hide Intro
Moderator: shell3, GOLD DIGGAA, AMG, FreezeThese, euroconversions
Search This Board: 
Last Post: 3/22/2019 10:41:45 AM - Followers: 308 - Board type: Free - Posts Today: 0

Cannabix Technologies Inc.

(formerly West Point Resources Inc.)

Frankfurt: 8CT:FRA)

And is a Vancouver, B.C. based  company

Cannabix Technologies Inc. has
the exclusive North American license for
the Cannabix Marijuana Breathalyzer
from Cannabix Breathalyzer Inc.

Cannabix Technologies Inc. has
Worldwide Rights to
Partial ovoidal FAIMS electrode"
Patent 8,237,118
from the University of Florida



Rights for 10 Years after 1st Product sold

What is FAIMS-MS?

It Blocks Out Unwanted Molecules
 Letting only THC Molecules Threw the Electrode
40 Minute Video with Dr Yost


Cannabix Technologies' Inc. common shares trade on
the Canadian Securities Exchange
and US OTC Pinksheets and European Frankfurt Exchange.

US Patent Application

Canada Patent Application

Cannabix Technologies Inc. is the developer of the patent pending Cannabix Marijuana Breathalyzer for law enforcement and the workplace. The Cannabix Marijuana Breathalyzer drug-impairment recognition system is based on breath testing technology that has been developed to test individuals for recent consumption of the THC component of marijuana.  Cannabix is advancing its products to enable law enforcement personnel to use this technology to enhance detection of marijuana impaired driving offences on North American roads at a time when marijuana is becoming legal in many jurisdictions.  Cannabix is working to develop a drug-testing device that will detect Tetrahydrocannabinol (THC- the psychoactive component of marijuana that causes intoxication) using breath samples. The device would be used to provide detection of THC at the roadside to identify drivers intoxicated by the use of marijuana. The device will also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous.
The device is currently in BETA 1.0 development and the Company is rapidly developing this technology for BETA 2.0 for Third Party Testing 


CSE:BLO          Pinksheets: BLOZF  Frankfurt: 8CT:FRA

Common Shares
Issued and Outstanding 
 (as of May 5th, 2018)
Warrants Issued but not Exercised  
Options Issued but not Exercised  7,076,000
IF a Patent is Issued another 5M Shares

Fully Diluted w/Warrants, w/Options  and w/Patent 5M Shares


Cannabix Corporate Video

Kal Malhi, President and Director
Kal Malhi, President, Director Mr. Malhi is a Vancouver based entrepreneur and the founder of Cannabix Breathalyzer Inc.  Mr. Malhi is a retired member of the Royal Canadian Mounted Police and is also President of BullRun Group, a private investment company specializing in early stage business development.  Mr Malhi brings a wealth of business and law enforcement experience to the management team and is cognizant of the issues of protecting individuals’ rights to privacy while maximizing public safety through law enforcement initiatives.

Dr. Raj Attariwala, MD, PhD.,  Lead Engineer
Dr. Attariwala is a Vancouver based dual board certified Radiologist and Nuclear Medicine physician certified in both Canada and the United States. He received his formal medical training at University of British Columbia with periods of specialized medical training at Memorial Sloan Kettering Cancer Centre (New York), UCLA and USC. He holds a doctorate in Biomedical Engineering from Northwestern University (Evanston, IL).  Dr.  Attariwala is a practicing physician in British Columbia and is the owner of AIM medical imaging in Vancouver.  He has pioneered advances in the field of whole body medical imaging thru his work and authored numerous publications and presented at international medical conferences on whole body imaging and cancer detection. Dr Attariwala has worked closely with the breath testing technology developed by the Karolinska Institute and Dr Olof Beck and utilized his educational training and background in Biomedical Engineering to formulate product design and patent applications for Cannabix Breathalyzer products.  Dr.  Attariwala also has several other medical device patents under developments in the field of Nuclear Medicine.

Dr. Bruce Goldberger, PhD,  Senior Advisor
Dr. Goldberger is a professor, and the director of toxicology for the Department of Pathology, Immunology and Laboratory Medicine in the College of Medicine at the University of Florida.  Dr. Goldberger is the editor-in-chief of the Journal of Analytical Toxicology; the president of the American Board of Forensic.

Richard A. Yost Ph.D., Scientific Advisor

Dr. Yost, Col. Allen R. & Margaret G. Crow Professor and Head of Analytical Chemistry at the University of Florida received his B.S. degree in Chemistry from the University of Arizona in 1974. In 1975 he pursued an NSF graduate fellowship at Michigan State University focusing on electronics and computerized instrumentation. He received his Ph.D. in 1979 and assumed the position of Assistant Professor at the University of Florida and went on to become head of the Analytical Chemistry Division.

Jared Boock Ph.D, Principal investigator
Worked on a high-field asymmetric waveform ion mobility spectrometry (FAIMS) - based
method of detection for transition metals. Conducted characterization of the types of ions that form
during the electrospray ionization (ESI) process for over 25 metal salts. Invented an atmospheric
pressure ion guide (patent pending). Taught four semesters of analytical chemistry laboratory; recipient of the Department of Chemistry Teaching Award for 2015.

Rocco Iannapollo, Advisor
Mr. Iannapollo is an expert on substance abuse programs with more than 20 years of experience in the oil and gas industry, working for fortune 50 companies. Rocco has extensive experience with supplier, employer, and DOT compliance policies and strategies. He also brings deep business acumen regarding operations and supply chain best practices. Mr. Iannapollo is a member of the Substance Abuse Program Administrator’s Association (SAPAA), the Drug and Alcohol Testing Industry Association (DATIA), as well as a speaker and regular contributor to the International Forum for Drug and Alcohol Testing (IFDAT).

Rav Mlait, MBA – CEO, Director
.Mr. Mlait has extensive experience in managing and raising capital for public and private companies. Mr. Mlait holds an MBA from Royal Roads University in British Columbia with a specialization in Executive Management and his BA (Economics) from Simon Fraser University and has worked with public companies listed on the TSX and TSX Venture exchange. Mr. Mlait was VP of Corporate development for knowledge-management and CRM software developer, Knexa Solutions Ltd., and financial web portal, Stockhouse Media Corporation.

Bryan Loree BA, CMA –CFO, Director
Mr. Loree has held various senior accounting roles for public and private companies in various industries including, renewable energy, exploration, and construction. During this time he has also performed capital raising activities for both private and public companies, primarily in the exploration and renewable energy sectors. Prior to entering the accounting field, Mr. Loree spent three years as an investor relations manager for public exploration companies and two years in the banking industry. Mr. Loree holds a Certified Management Accountant designation, a Financial Management Diploma from the British Columbia Institute of Technology, and a BA from Simon Fraser University.

Thomas Clarke, M,Sc, Director
Mr. Clarke served as a geologist for TSX Venture listed, BonTerra Resources from May 2010 to October, 2012. During his tenure, BonTerra defined an initial NI 43-101 compliant resource under his leadership. Thomas is a geologist holding a BSc. (Honours) and MSc in Geology from the University of the Witwatersrand as well as a BSc in Geography from the University of Lethbridge. 

Andrew Davies,  Advisor
Mr. Davies is a cannabinoid expert who has over 25 years of experience in the pharmaceutical industry and was instrumental in securing the first US IND for synthetic Cannabidiol (CBD) at Yale University. Andrew is a Chartered Mechanical Engineer and holds a BEng from the University of Liverpool and an International Executive MBA from the University of Middlesex Business School, London. Andrew is the CEO of STI Pharmaceuticals Ltd., a leading cannabinoid research company based in London, England. He is also a sought after speaker at cannabinoid conferences globally.

Dr. (h.c.) Marilyn Huestis, PhD, Scientific Advisor
Dr. Huestis is one of the world’s foremost experts on the effects of marijuana use on driving impairment. Dr. Huestis is a sought after international speaker, scholar and scientist. Dr. Huestis was a tenured Senior Investigator and Chief of Chemistry and Drug Metabolism at National Institute for Drug Abuse (NIDA’s) Intramural Research Program (IRP) in Baltimore, Maryland and a Professor at the University of Maryland School of Medicine (retired in 2016).  Dr. Huestis received her Bachelor’s degree (cum laude) in Biochemistry from Mount Holyoke College, a Master's in Clinical Chemistry with honors from the University of New Mexico, and a Ph.D. in Toxicology with honors from the University of Maryland School of Medicine. 

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BLOZF News: Cannabix Technologies Provides Update on Marijuana Breathalyzer Development 03/14/2019 05:40:00 AM
BLOZF News: Cannabix Technologies Completes Breath Collection Unit and Provides Update 01/28/2019 08:45:00 AM
BLOZF News: Cannabix Technologies Engages MistyWest - Provides Development Update on Marijuana Breathalyzer 11/15/2018 08:45:00 AM
BLOZF News: Cannabix Technologies Comments on Legalization of Marijuana in Canada, Impaired Driving and Workplace Safety 10/16/2018 08:45:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#24317  Sticky Note Cannabix Technologies Engages MistyWest - Provides Development Update FreezeThese 11/15/18 09:00:24 AM
#22892  Sticky Note Patent Pending Cannabis Drug Detection Device: I recommend you euroconversions 07/09/18 04:39:05 PM
#21936  Sticky Note Cannabix Technologies Files FAIMS Cannabis Detection Patent shell3 04/16/18 04:20:52 PM
#25033   DD Fraud Research Team @ IHub will weed AMG 03/22/19 10:41:45 AM
#25032   My bad...meant to post at ALGERNON...sorry. LongNDeep2 03/22/19 10:29:45 AM
#25031   Ignorance and Denial...Running Rampant at ALGERNON LongNDeep2 03/22/19 09:54:30 AM
#25030  Restored P.S. I will have cashed in my Anon AMG 03/21/19 07:08:04 PM
#25029   Lol...we know shell. We know. I keep a AMG 03/21/19 08:53:21 AM
#25028   BTHCF adds to the Advisory Board shell3 03/21/19 07:48:12 AM
#25027   Nj.. votes next week on Recreational Weed. The Carthnel 03/21/19 07:36:08 AM
#25026   FYI 4 All: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147689 AMG 03/21/19 02:57:24 AM
#25025   OK, I'm still hanging in there but just dilligence 03/21/19 12:03:36 AM
#25024   I hear ya Shell, 4 years deep meself FreezeThese 03/20/19 03:42:26 PM
#25022   I’ll get concerned if the same bla bla UTW 03/20/19 11:44:05 AM
#25021   I too say I’m getting tired of hearing shell3 03/20/19 11:18:37 AM
#25020   I prefer they wait until something newsworthy transpires FreezeThese 03/20/19 10:58:27 AM
#25019   More news coming this month. UTW 03/20/19 10:41:02 AM
#25018   https://insiderfinancial.com/cannabix-technologies-inc-otcmktsblozf-game-changer UCParadise 03/19/19 01:46:21 PM
#25017   March 15, 2019 MD&A carramrod 03/19/19 10:52:37 AM
#25016   Published in cooperation with the American Society for carramrod 03/18/19 11:32:51 PM
#25015   UTW - AMG 03/18/19 10:20:49 PM
#25014   If you really feel Breathtec is still around UTW 03/18/19 10:15:11 PM
#25013   https://www.microcapdaily.com/the-inside-scoop-on-cannabix-technologies-inc-otcm drt1111 03/18/19 06:33:49 PM
#25012   P.S.S.S. Breathtec common shareholders paid in spades for AMG 03/18/19 05:35:04 PM
#25011   .. like reading lines from SNL :)))))) smoki 03/18/19 05:08:31 PM
#25010   P.S.S. As I stated in a previous post, AMG 03/18/19 05:03:18 PM
#25009   LMAO. Sounds like RABID speculation to me... AMG 03/18/19 04:37:01 PM
#25008   It seems to me after Owlstone Medical spent UTW 03/18/19 03:37:32 PM
#25007   I’ll conceed that a deal was made between UTW 03/18/19 03:09:44 PM
#25006   I am not buying that the BCU is UCParadise 03/18/19 02:31:32 PM
#25005   “A unique gating system has been developed that UTW 03/18/19 12:15:59 PM
#25004   I agree 100% that the BCU is for UTW 03/18/19 11:59:26 AM
#25003   https://www.innovation.ca/about/news/government-canada-investing-canadian-resear Carthnel 03/18/19 08:41:47 AM
#25002   I agree AMG......I believe that device came to Carthnel 03/17/19 01:03:55 PM
#25001   Hey Rags...I understand the frustration. Here's a question AMG 03/17/19 03:55:46 AM
#24998   In my opinion the breath sample must filter AMG 03/16/19 12:12:54 PM
#24996   My hope is the BCU will collect the UCParadise 03/16/19 09:56:48 AM
#24995   https://stockhouse.com/companies/bullboard?symbol=c.blo&postid=29495125 AMG 03/16/19 05:41:37 AM
#24994   That link u posted in regards to the geodcan 03/15/19 08:37:18 PM
#24993   Nice Find - Have a good Weekend shell3 03/15/19 05:07:30 PM
#24992   https://cbdoilreviews.com/cannabix-technologies/ UCParadise 03/15/19 02:02:37 PM
#24991   Agreed. Any Shorty willing to play that game AMG 03/15/19 10:50:23 AM
#24990   Shorties going to be covering. Good stuff... GOLD DIGGAA 03/15/19 09:58:15 AM
#24988   So now it’s Karma.... Carthnel 03/15/19 07:14:23 AM
#24986   So now its a pharma...that's why things are AMG 03/14/19 01:44:17 PM
#24985  Restored I think there may be some here that Ragstoriches465 03/14/19 01:33:37 PM
#24984   News: $BLOZF Cannabix Technologies Provides Update on Marijuana whytestocks 03/14/19 01:30:38 PM
#24983   I believe your current assessment is correct. dilligence 03/14/19 12:12:12 PM
#24982   The Breath Collection Unit (Handheld Device) couples with AMG 03/14/19 11:24:34 AM
#24981   Yep, chasing the thc9***+ molecules seems to be tcm7 03/14/19 11:19:57 AM
#24979   I agree that has been needed shell3 03/14/19 09:52:28 AM
#24978   That helps Thank You Management for update. Carthnel 03/14/19 09:18:21 AM
#24977   NEWS March 14, 2019 drt1111 03/14/19 08:47:59 AM